Full year 2025 revenue and Adjusted EBITDA guidance reaffirmed to be in the range of $3.30 billion to $3.45 billion and $555 million to $565 million, respectively
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGRY:
- Surgery Partners Inc. (SGRY) Q2 Earnings Cheat Sheet
- BofA changes Surgery Partners rating to Buy
- Surgery Partners upgraded to Buy from Neutral at BofA
- TD says CMS hospital rules positive for Surgery Partners, negative for HCA
- Positive Outlook for Surgery Partners Amid CMS Regulatory Changes Boosting ASC Opportunities